118 related articles for article (PubMed ID: 30544746)
21. Serum IL-17 levels can be diagnostic for gastric cancer.
Karabulut M; Usul Afsar C; Serimez M; Karabulut S
J BUON; 2019; 24(4):1601-1609. PubMed ID: 31646815
[TBL] [Abstract][Full Text] [Related]
22. Clinical impact of different exosomes' protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy.
Giampieri R; Piva F; Occhipinti G; Bittoni A; Righetti A; Pagliaretta S; Murrone A; Bianchi F; Amantini C; Giulietti M; Ricci G; Principato G; Santoni G; Berardi R; Cascinu S
PLoS One; 2019; 14(5):e0215990. PubMed ID: 31048929
[TBL] [Abstract][Full Text] [Related]
23. The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib.
Faloppi L; Bianconi M; Giampieri R; Sobrero A; Labianca R; Ferrari D; Barni S; Aitini E; Zaniboni A; Boni C; Caprioni F; Mosconi S; Fanello S; Berardi R; Bittoni A; Andrikou K; Cinquini M; Torri V; Scartozzi M; Cascinu S;
Oncotarget; 2015 Oct; 6(33):35087-94. PubMed ID: 26397228
[TBL] [Abstract][Full Text] [Related]
24. Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer.
Chen IM; Willumsen N; Dehlendorff C; Johansen AZ; Jensen BV; Hansen CP; Hasselby JP; Bojesen SE; Pfeiffer P; Nielsen SE; Holländer NH; Yilmaz MK; Karsdal M; Johansen JS
Int J Cancer; 2020 May; 146(10):2913-2922. PubMed ID: 31642523
[TBL] [Abstract][Full Text] [Related]
25. Serum DJ-1 as a diagnostic marker and prognostic factor for pancreatic cancer.
He XY; Liu BY; Yao WY; Zhao XJ; Zheng Z; Li JF; Yu BQ; Yuan YZ
J Dig Dis; 2011 Apr; 12(2):131-7. PubMed ID: 21401899
[TBL] [Abstract][Full Text] [Related]
26. Serum APN/CD13 as a novel diagnostic and prognostic biomarker of pancreatic cancer.
Pang L; Zhang N; Xia Y; Wang D; Wang G; Meng X
Oncotarget; 2016 Nov; 7(47):77854-77864. PubMed ID: 27788483
[TBL] [Abstract][Full Text] [Related]
27. Survivin expression and serum levels in pancreatic cancer.
Dong H; Qian D; Wang Y; Meng L; Chen D; Ji X; Feng W
World J Surg Oncol; 2015 May; 13():189. PubMed ID: 26016480
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-145 suppresses cell proliferation, invasion and migration in pancreatic cancer cells by targeting NEDD9.
Han T; Yi XP; Liu B; Ke MJ; Li YX
Mol Med Rep; 2015 Jun; 11(6):4115-20. PubMed ID: 25646678
[TBL] [Abstract][Full Text] [Related]
29. CEA and CA-19.9 serum tumor markers as prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis.
Tsavaris N; Kosmas C; Papadoniou N; Kopterides P; Tsigritis K; Dokou A; Sarantonis J; Skopelitis H; Tzivras M; Gennatas K; Polyzos A; Papastratis G; Karatzas G; Papalambros A
J Chemother; 2009 Dec; 21(6):673-80. PubMed ID: 20071292
[TBL] [Abstract][Full Text] [Related]
30. miR-5195-3p Suppresses Cell Proliferation and Induces Apoptosis by Directly Targeting NEDD9 in Osteosarcoma.
Wang L; Shi G; Zhu D; Jin Y; Yang X
Cancer Biother Radiopharm; 2019 Aug; 34(6):405-412. PubMed ID: 31411930
[No Abstract] [Full Text] [Related]
31. NEDD9 crucially regulates TGF-β-triggered epithelial-mesenchymal transition and cell invasion in prostate cancer cells: involvement in cancer progressiveness.
Morimoto K; Tanaka T; Nitta Y; Ohnishi K; Kawashima H; Nakatani T
Prostate; 2014 Jun; 74(8):901-10. PubMed ID: 24728978
[TBL] [Abstract][Full Text] [Related]
32. Expression and clinical significance of NEDD9 in lung tissues.
Chang JX; Gao F; Zhao GQ; Zhang GJ
Med Oncol; 2012 Dec; 29(4):2654-60. PubMed ID: 22447485
[TBL] [Abstract][Full Text] [Related]
33. Impact of the integrin signaling adaptor protein NEDD9 on prognosis and metastatic behavior of human lung cancer.
Kondo S; Iwata S; Yamada T; Inoue Y; Ichihara H; Kichikawa Y; Katayose T; Souta-Kuribara A; Yamazaki H; Hosono O; Kawasaki H; Tanaka H; Hayashi Y; Sakamoto M; Kamiya K; Dang NH; Morimoto C
Clin Cancer Res; 2012 Nov; 18(22):6326-38. PubMed ID: 23037767
[TBL] [Abstract][Full Text] [Related]
34. Expression of Nedd9 in Transbronchial Biopsies of Lung Adenocarcinoma.
Ostojić J; Brčić L; Hrabač P; Seiwerth S
Acta Clin Croat; 2018 Jun; 57(2):251-256. PubMed ID: 30431717
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of serum survivin in patients with pancreatic ductal adenocarcinoma.
Ren YQ; Zhang HY; Su T; Wang XH; Zhang L
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(20):3063-8. PubMed ID: 25392106
[TBL] [Abstract][Full Text] [Related]
36. Prognostic and diagnostic value of REG4 serum and tissue expression in pancreatic ductal adenocarcinoma.
Saukkonen K; Hagström J; Mustonen H; Lehtinen L; Carpen O; Andersson LC; Seppänen H; Haglund C
Tumour Biol; 2018 Mar; 40(3):1010428318761494. PubMed ID: 29542402
[TBL] [Abstract][Full Text] [Related]
37. Serum transforming growth factor-beta1 levels may have predictive and prognostic roles in patients with gastric cancer.
Tas F; Yasasever CT; Karabulut S; Tastekin D; Duranyildiz D
Tumour Biol; 2015 Mar; 36(3):2097-103. PubMed ID: 25391430
[TBL] [Abstract][Full Text] [Related]
38. Is there any diagnostic value of serum caveolin-1 levels on the determination of pancreatic adenocarcinoma?
Karabulut S; Afsar CU; Paksoy N; Ferhatoglu F; Dogan I; Tastekin D
J Cancer Res Ther; 2024 Jan; ():. PubMed ID: 38261434
[TBL] [Abstract][Full Text] [Related]
39. Involvement of NEDD9 in the invasion and migration of gastric cancer.
Feng J; Zhao J; Xie H; Yin Y; Luo G; Zhang J; Feng Y; Li Z
Tumour Biol; 2015 May; 36(5):3621-8. PubMed ID: 25577245
[TBL] [Abstract][Full Text] [Related]
40. Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.
Hua Y; Chen H; Wang L; Wang F; Wang P; Ning Z; Li Y; Liu L; Chen Z; Meng Z
Cancer Biomark; 2017 Jul; 20(1):95-100. PubMed ID: 28759959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]